Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

BACKGROUND: Negative symptoms in schizophrenia are associated with impairments in social and cognitive functioning leading to substantial long-term disability. Available antipsychotic treatments have demonstrated only modest benefit in the improvement of negative symptoms. OBJECTIVE: To compare impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopal, Srihari, Gogate, Jagadish, Pungor, Katalin, Kim, Edward, Singh, Arun, Mathews, Maju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064291/
https://www.ncbi.nlm.nih.gov/pubmed/32184607
http://dx.doi.org/10.2147/NDT.S226296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064291/
https://www.ncbi.nlm.nih.gov/pubmed/32184607
http://dx.doi.org/10.2147/NDT.S226296

Ejemplares similares